American Society for Blood and Marrow Transplantation Corporate

American Society for Blood and Marrow Transplantation Corporate Council Meeting 2018

Management Company Change ¡Search for a new company started mid-year 2017 ¡Retained a consulting firm to assist in the search that lasted several months ¡Narrowed down to three finalists ¡Selected Smith. Bucklin and moved in April

Why Smith. Bucklin ¡A leader in Association Management ¡Over 70 years of experience ¡Depth of resources ¡IT ¡Marketing ¡Event planning ¡Education ¡Clients represent a wide variety of industries

ASBMT Leadership Team ¡Andre Williams – Executive Director ¡Mollie Corbett – Sr. Manager Operations ¡Kirk Terri – Manager Education

ASBMT Leadership Team ¡Jennifer Kasowicz – Director Marketing ¡Stephanie Farnia – Director of Health Policy & Strategic Relations ¡Angie Dahl – Director of Development

Current Membership Member Affiliate Member Associate Member In-Training Member International Total Active Members 8/27/2018 1181 495 128 216 6 2026

CAR T Consensus Conference ¡ Held in June in DC ¡Invitation only conference ¡ Goals ¡Generate consensus opinion on the scales used to diagnose CAR T toxicities ¡Discuss reporting issues REMS vs CIBMTR ¡ 49 attends including 9 industry representatives ¡ Outcome – white paper

Tandem Meetings ¡Renamed to the TCT Meetings – Transplantation and Cellular Therapy Meetings of ASBMT and CIBMTR ¡Name changed to better reflect our societies range of interests and activities ¡Expecting close to 4000 attendees ¡Held February 20 -24, 2019 in Houston, TX

TCT Meetings ¡Annual meeting, held jointly with the CIBMTR ¡The largest gathering in North America of worldwide experts in blood and marrow transplant patient care, clinical investigation and laboratory research ¡Scientific sessions and workshops cover the most recent laboratory and clinical developments in cellular therapy and BMT

TCT Meetings ¡ 3, 878 Registrants in 2018 ¡ 82% Domestic Attendees ¡ 18% International Attendees ¡Participant Demographics ¡ 32% Physicians (MDs) and Researchers (Ph. Ds) ¡ 12% Nurses ¡ 8% Exhibitors ¡ 7% Advanced Practice Professionals ¡ 5% Pharmacists ¡ 5% Fellows-in-Training

Annual Meeting Registration 4, 500 4, 000 3, 500 3, 000 2, 500 2, 000 1, 500 1, 000 500 0 2002 2004 2006 2008 2010 2012 2014 2016 2018

TCT Scientific Agenda ¡Plenary Sessions in 2019: ¡Novel Approaches for Prevention of Gv. HD (Chair: Ivan Maillard) ¡Life After CD 19 CAR-T (Chair: Anastasios Karadimitris) ¡Cell and Gene Therapy: The Next Big Challenges (Chair: John Di. Persio) ¡Novel Approaches for HSCT Engraftment (Chair: John Chute) ¡Biology, Genomics and Immunology of Relapse after Transplantation (Chair: Matthew Walter)

Mobil App Introduction of the ASBMT Practice Guidelines App in 2016 ¡Downloaded over 3200 times ¡Largest participation from: ¡USA 1260 ¡SPAIN 87 ¡INDIA 83 ¡BRAZIL 77 ¡CANDA 68

BBMT ¡The Society’s official journal, Biology of Blood and Marrow Transplantation, was launched in 1995: ¡Members consider BBMT second only to Blood for content relevance. ¡Impact factor of 4. 48

BBMT ¡Over 500 submissions to date ¡Over 1770 pages published ¡ 67. 7 abstracts submitted per month ¡Rejection rate around 53% ¡Over 50% of the manuscripts submitted from outside the US

Asia/Pacific BMT Society Partnership • APBMT Joint Members receive all current member benefits: • • Registration discounts to TCT meetings of ASBMT and CIBMTR • ASBMT Newsletter Access to other events and networking opportunities Participation in SIGs and Committees Educational resources, including practice improvement guidelines and patient outcomes • Digital Journal access

Clinical Research Training Course ¡In 2006 the Board of Directors identified training as an important unmet education need in training BMT fellows ¡Each year twelve fellows are selected to participate in this course based on their curriculum vitae ¡Wide range of topics represented in the scholars presentations: ¡Novel cell therapies ¡GVHD prophylaxis or treatment ¡Gut microbiome ¡Novel conditioning regimens ¡Maintenance therapies post-allo. SCT

Clinical Research Training Course ¡Both adult and pediatric scholars and research projects ¡Scholars were “wicked smart, high energy, committed to academia, fully engaged” said, Dr. Bredesen, CRTC Co-chair ¡The faculty all felt rejuvenated after spending a week with our future!

Clinical Research Training Course ¡“Our formal and informal interactions with the faculty helped us realize the opportunities, rewards and challenges in the field, straight from the people who have seen it all — and the opportunities are infinite. ” Tania Jain, MBBS, Memorial Sloan Kettering Cancer Center, Scholar and recipient of the H. Jean Khoury Award for Scholarly Excellence

Strategic Planning - October ASBMT’s Current Goals ¡Is known as the clinical and translational experts in cellular therapy and transplantation biology ¡Has established a recognized credentialing program in clinical stem cell transplantation ¡Has attracted more medical professionals and scientists to the field ¡Has reduced barriers to access to cellular therapy and increased understanding of the field

Strategic Planning - October Preparation Questionnaire to membership ¡ What does the membership value from ASBMT ¡ What would it like to see more of – opportunities for improvement or expansion ¡ What would it like to see less of; is ASBMT doing anything that is not adding value? ¡ Free form comments on four priority areas ¡ What should be the outcome of pursuing these priorities ¡ How best to pursue the priorities ¡ Are some priorities more important than others

Strategic Planning - October Things to consider in our planning ¡Developing relevance in cellular therapy ¡Current status and thinking on credentialing/certification programs ¡Membership growth ¡Reducing barriers with specific emphasis on payer policy ¡Fundraising ¡Stakeholder feedback

Questions?

Thank you